Advances in ureteral stent design

Journal of Endourology

Volumn 17, Issue 4, 2003, Pages 195-199

  Beiko, Darren T ^a   Knudsen, Bodo E ^a   Denstedt, John D ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CARBOXYLYASE; DEXAMETHASONE; HEPARIN; LIPOSOME; NICKEL; NITINOL; OXYGEN; PENTOSAN POLYSULFATE; PHOSPHORYLCHOLINE; POLYETHERURETHAN; POLYGLACTIN; POLYLACTIC ACID; POLYMER; POLYSACCHARIDE; POLYURETHAN; POVIDONE; SILICONE; TITANIUM; TRANSFERASE;

BLADDER IRRITATION; CLINICAL TRIAL; CYSTOSCOPY; HUMAN; HYDROGEL; INFECTION; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; URETER STENT; URINARY TRACT DISEASE;

EID: 0037982667     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277903765444294     Document Type: Review

References (38)

1. Finney RP. Experience with new double-J ureteral catheter stent. J Urol 1978;120:678.
2. Hepperlen TK, Mardis HK. Pigtail stent termed means of lessening ureteral surgery. Trends Clin Urol 1978;1:405.
3. Watterson JD, Cadieux P, Denstedt JD. Ureteral stents: Which, when, and why? AUA Update Series 2002;21(16):122.
4. Marx M, Bettmann MA, Bridge S, et al. The effects of various in-dwelling ureteral catheter materials on the normal canine ureter. J Urol 1988;139:180.
5. Denstedt JD, Wollin TA, Reid G. Biomaterials used in urology: Current issues of biocompatibility, infection, and encrustation. J Endourol 1998;12:493.
6. Lam JS, Volpe MA, Kaplan SA. Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients. Curr Urol Rep 2001;2:277.
7. Kulkarni RP, Bellamy EA. A new thermo-expandable shape-memory nickel-titanium alloy stent for the management of ureteric strictures. BJU Int 1999;83:755.
8. Mardis HK, Kroeger RM. Ureteral stents: Materials. Urol Clin North Am 1988;15:471.
9. Laaksovirta S, Laurila M, Isotalo T, et al. Rabbit muscle and urethral in situ biocompatibility properties of the self-reinforced L-lactide-glycolic acid copolymer 80:20 spiral stent. J Urol 2002;167:1527.
10. Laaksovirta S, Isotalo T, Talja M. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement. J Endourol 2002;16:311.
11. Ko GY, Kim GC, Seo TS, et al. Covered, retrievable, expandable urethral Nitinol stent: Feasibility study in dogs. Radiology 2002;223:83.
12. Olweny EO, Landman J, Andreoni C, et al. Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. J Urol 2002;167:2198.
13. Auge BK, Ferraro RF, Madenjian AR, Preminger GM. Evaluation of a dissolvable ureteral drainage stent in a swine model. J Urol 2002;168:808.
14. Lingeman JE, Preminger GM, Segura JW, et al. Use of a temporary ureteral drainage stent (TUDS) after uncomplicated ureteroscopy. J Urol (in press).
15. Amiel GE, Yoo JJ, Kim BS, Atala A. Tissue engineered stents created from chondrocytes. J Urol 2001;165:2091.
16. Tunney MM, Gorman SP. Evaluation of a poly(vinyl pyrrolidone)-coated biomaterial for urological use. Biomaterials 2002;23:4601.
17. Stickler DJ, Evans A, Morris N, Hughes G. Strategies for the control of catheter encrustation. Int J Antimicrob Agents 2002;19:499.
18. Riedl CR, Witkowski M, Plas E, Pflueger H. Heparin coating reduces encrustation of ureteral stents: A preliminary report. Int J Antimicrob Agents 2002;19:507.
19. Zupkas P, Parsons CL, Percival C, Monga M. Pentosanpolysulfate coating of silicone reduces encrustation. J Endourol 2000;14:483.
20. Sidhu H, Ogden SE, Lung HY, et al. DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Ox-alobacter formigenes. J Bacteriol 1997;179:3378.
21. Lung HY, Baetz AL, Peck AB. Molecular cloning, DNA sequence, and gene expression of the oxalyl coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes. J Bacteriol 1994;176:2468.
22. Watterson JD, Cadieux PA, Beiko DT, et al. Oxalate-degrading enzymes from Oxalobacter formigenes: A novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol (in press).
23. Multanen M, Tammela TL, Laurila M, et al. Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra. Urol Res 2002;30:227.
24. Tschada RK, Henkel TO, Junemann KP, et al. Spiral-reinforced ureteral stent: An alternative for internal urinary diversion. J Endourol 1994;8:119.
25. Stoller ML, Schwartz BF, Frigstad JR, et al. An in vitro assessment of the flow characteristics of spiral-ridged and smooth-walled JJ ureteric stents. BJU Int 2000;85:628.
26. Olweny EO, Portis AJ, Sundaram CP, et al. Evaluation of a chronic indwelling prototype mesh ureteral stent in a porcine model. Urology 2000;56:857.
27. Brewer AV, Elbahnasy AM, Bercowsky E, et al. Mechanism of ureteral stent flow: A comparative in vivo study. J Endourol 1999;13:269.
28. Dunn MD, Portis AJ, Kahn SA, et al. Clinical effectiveness of new stent design: Randomized single-blind comparison of tail and double-pigtail stents. J Endourol 2000;14:195.
29. Liatsikos EN, Hom D, Dinlenc CZ, et al. Tail Stent versus reentry tube: A randomized comparison after percutaneous stone extraction. Urology 2002;59:15.
30. Mardis HK, Kroeger RM, Morton JJ, Donovan JM. Comparative evaluation of materials used for internal ureteral stents. J Endourol 1993;7:105.
31. Kay A. Boston Scientific/Microvasive®'s Polaris™ dual durometer ureteral stent: The next generation in stent materials and design [abstract]. J Endourol 2002;16(suppl):8.
32. Mardis HK. Standard specification for ureteral stents: A comparative evaluation of newer devices [abstract]. J Urol 2001;165(suppl):362.
33. Macaluso JN Jr, Deutsch JS, Goodman JR, et al. The use of the Magnetip double-J ureteral stent in urological practice. J Urol 1989;142:701.
34. Mykulak DJ, Herskowitz M, Glassberg KI. Use of magnetic internal ureteral stents in pediatric urology: Retrieval without routine requirement for cystoscopy and general anesthesia. J Urol 1994;152:976.
35. Taylor WN, McDougall IT. Minimally invasive ureteral stent retrieval. J Urol 2002;168:2020.
36. Hiatt BL, Ikeno F, Yeung AC, Carter AJ. Drug-eluting stents for the prevention of restenosis: In quest for the Holy Grail. Catheter Cardiovasc Interv 2002;55:409.
37. Antimisiaris SG, Siablis D, Liatsikos E, et al. Liposome-coated metal stents: An in vitro evaluation of controlled-release modality in the ureter. J Endourol 2000;14:743.
38. Slepian MJ. Polymeric endoluminal gel paving: Therapeutic hydrogel barriers and sustained drug delivery depots for local arterial wall biomanipulation. Semin Intervent Cardiol 1996;1:103.